Pharma Giants Combine Forces to Fight New M&A Rules
The Motley Fool
OCTOBER 4, 2023
With a looming overhaul of US merger-and-acquisition law set to reshape the economics of the M&A-heavy pharmaceutical industry, 31 of its biggest players -- including Merck, Amgen, Abbvie, and Gilead -- formed an alliance to fight the reforms. billion merger with Horizon Therapeutics. Meet the anti-antitrust coalition.
Let's personalize your content